Ig G at least 96% (IgG1 65%, IgG2 30%, IgG3 3%, IgG4 2%)
containing antibiotics against cytomegalovirus (CMV) of 100U
Package size
50 mL/bottle
Indication
Prophylaxis of clinical manifestations of cytomegalovirus infection in patients subjected to immunosuppressive therapy, particularly in transplant recipients. The concomitant use of adequate virostatic agents should be considered for CMV-prophylaxis.